Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 81, Iss. 1, 2005-05 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 317-324

Karger

Access to resources Recommend Favorite

The Novel mTOR Inhibitor RAD001 (Everolimus) Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 85, Iss. 1, 2007-02 ,pp. : 54-60

Karger

Access to resources Recommend Favorite

DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 105, Iss. 2, 2016-11 ,pp. : 170-181

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents

By  

Neuroendocrinology, Vol. 105, Iss. 3, 2017-03 ,pp. : 266-280

Karger

Access to resources Recommend Favorite